We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+12.13%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$32.7B
AUM Growth
+$651M
(+2%)
Cap. Flow
-$2.75B
Cap. Flow
% of AUM
-8.41%
Top 10 Holdings %
Top 10 Hldgs %
20.41%
Holding
1,997
New
181
Increased
978
Reduced
793
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$146M |
| 2 |
Albemarle
ALB
|
+$38M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$32.7M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$30.8M |
| 5 |
J.M. Smucker
SJM
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$420M |
| 2 |
Microsoft
MSFT
|
+$382M |
| 3 |
Amazon
AMZN
|
+$209M |
| 4 |
NVIDIA
NVDA
|
+$163M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Industrials | 12.61% |
| 3 | Consumer Staples | 11.87% |
| 4 | Financials | 10.22% |
| 5 | Consumer Discretionary | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Heron Therapeutics
HRTX
$90.9M
| $29.1K | ﹤0.01% |
17,138
+3,685
| +27% | +$4.06K |
|
1902
Ring Energy
REI
$327M
| $29K | ﹤0.01% |
19,852
+4,271
| +27% | +$7.03K |
|
|
VTYX
1903
DELISTED
Ventyx Biosciences
VTYX
| $28.5K | ﹤0.01% |
11,519
+1,589
| +16% | +$15.1K |
|
1904
BlackSky Technology
BKSY
$811M
| $27.7K | ﹤0.01% |
2,473
+531
| +27% | +$5.39K |
|
|
NVTA
1905
DELISTED
Invitae Corporation
NVTA
| $27.3K | ﹤0.01% |
43,501
+9,358
| +27% | +$5.6K |
|
1906
Kaltura
KLTR
$209M
| $27.2K | ﹤0.01% |
13,949
+3,165
| +29% | +$5.59K |
|
|
BHR
1907
Braemar Hotels & Resorts
BHR
$145M
| $27.1K | ﹤0.01% |
+10,859
| New | +$27K |
|
1908
ThredUp
TDUP
$850M
| $26.7K | ﹤0.01% |
+11,884
| New | +$30.9K |
|
1909
Bakkt Inc
BKKT
$351M
| $26.3K | ﹤0.01% |
+471
| New | +$16.3K |
|
1910
Butterfly Network
BFLY
$1.75B
| $25.3K | ﹤0.01% |
23,453
+5,323
| +29% | +$5.27K |
|
|
TSP
1911
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $24.3K | ﹤0.01% |
27,697
+5,958
| +27% | +$6.09K |
|
1912
Lineage Cell Therapeutics
LCTX
$274M
| $23.9K | ﹤0.01% |
21,964
+5,198
| +31% | +$5.69K |
|
1913
Compass Therapeutics
CMPX
$364M
| $23.6K | ﹤0.01% |
15,104
+3,248
| +27% | +$5.62K |
|
1914
Seres Therapeutics
MCRB
$49.5M
| $22.5K | ﹤0.01% |
805
-246
| -23% | -$6.46K |
|
|
AMRN
1915
Amarin Corp
AMRN
$285M
| $21.4K | ﹤0.01% |
1,232
-26
| -2% | -$408 |
|
1916
Taysha Gene Therapies
TSHA
$1.6B
| $21.1K | ﹤0.01% |
+11,946
| New | +$23.8K |
|
1917
Rackspace Technology
RXT
$1.09B
| $20.9K | ﹤0.01% |
+10,472
| New | +$15.8K |
|
1918
Hyliion Holdings
HYLN
$633M
| $19.9K | ﹤0.01% |
24,435
+5,256
| +27% | +$3.73K |
|
1919
Smartbird Inc
BIRD
$23.2M
| $19.6K | ﹤0.01% |
801
+183
| +30% | +$3.61K |
|
1920
Protalix BioTherapeutics
PLX
$194M
| $19.5K | ﹤0.01% |
+10,979
| New | +$17.1K |
|
|
LLAP
1921
DELISTED
Terran Orbital Corporation
LLAP
| $18.7K | ﹤0.01% |
16,374
+5,304
| +48% | +$4.43K |
|
1922
BARK
BARK
$82M
| $17.8K | ﹤0.01% |
1,104
+237
| +27% | +$4.32K |
|
1923
ESS Tech
GWH
$24.6M
| $17.2K | ﹤0.01% |
1,007
+217
| +27% | +$4.41K |
|
1924
X4 Pharmaceuticals
XFOR
$347M
| $17.1K | ﹤0.01% |
679
+146
| +27% | +$3.55K |
|
1925
Aclaris Therapeutics
ACRS
$778M
| $16.8K | ﹤0.01% |
16,020
+2,361
| +17% | +$7.2K |
|
Similar funds
ProShare Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, ProShare Advisors held 1,997 positions worth $32.7B, up 2% from $32.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ProShare Advisors withdrew a net $2.75B in Q4 2023, closing 44 positions and reducing 793 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $40.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in DoorDash worth $28.6M.
- ProShare Advisors's largest Q4 2023 buy was DoorDash: 289,583 shares worth $28.6M.
- ProShare Advisors added most to Kenvue in Q4 2023, an estimated $146M increase.
- ProShare Advisors's biggest Q4 2023 reduction was Apple, cutting an estimated $420M.
- ProShare Advisors fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $40.1M.
- ProShare Advisors's ten largest holdings make up 20% of its $32.7B portfolio in Q4 2023.
- ProShare Advisors opened 181 new positions and closed 44 in Q4 2023.
- ProShare Advisors's portfolio value rose 2% quarter-over-quarter to $32.7B.
Based on ProShare Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.